Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition

Inhibition of epidermal growth factor receptor (EGFR) signalling has emerged as a new treatment strategy for oral squamous cell carcinoma (OSCC). Previously, we found that loss of EGFR expression in OSCC was associated with epithelial-mesenchymal transition (EMT), and may have functional implication...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitahara, Hiroko, Hirai, Mariko, Kato, Koroku, Bou-Gharios, George, Nakamura, Hiroyuki, Kawashiri, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112623/
https://www.ncbi.nlm.nih.gov/pubmed/27779690
http://dx.doi.org/10.3892/or.2016.5189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112623/
https://www.ncbi.nlm.nih.gov/pubmed/27779690
http://dx.doi.org/10.3892/or.2016.5189

Ejemplares similares